All Articles

China's top probiotics firm, WONDERLAB, is challenging the 'calories in, calories out' model with a new framework for precision, microbiome-based weight loss.

The new TL3 PRO introduces a novel chuck system and intelligent automation, promising to handle all tube sizes on one machine and slash production costs.

Cybersecurity leader Resecurity promotes founder Gene Yoo to Chairman and appoints COO Shawn Loveland as CEO, setting the stage for its next phase of innovation.

Kinetics' new FSRU is more than a vessel; it's a power play in the global energy chess match, betting big on flexible LNG to redefine energy security.

Avacta taps veteran dealmaker Dr. Patrick Vink as it nears a pivotal data reveal for its pre|CISION® platform, signaling a shift from R&D to high-stakes commercial strategy.

A new AI-powered age verification promises to end self-checkout delays. But as our faces become our IDs, are we trading privacy for convenience?

For children with the rare metabolic disorder MMA, a new gene therapy offers hope. Preclinical data reveals a potential one-time fix with lifelong effects.

Beyond its #17 ranking, World Travel Holdings reveals a blueprint for success. Discover how its blend of AI tools and strategic alliances is reshaping travel.

Mirantis now offers day-zero support for NVIDIA's next-gen chips, promising a 'forever factory' that eliminates costly infrastructure redesigns with each new hardware release.

With a major stake in Boohee Health, Ant Group is moving beyond finance, using its AI powerhouse AQ to tackle China's health challenges. What does this mean for the future of super apps and personal well-being?

With a new mega-fund on the horizon, Antin Infrastructure Partners' latest senior promotions in London signal a strategic play in a hyper-competitive market.

Bengaluru-based QpiAI has open-sourced its quantum SDK, a strategic move to democratize development, challenge global giants, and fuel India's national tech ambitions.

Protean eGov leverages its history building India's digital backbone to launch eSignPro, a suite aimed at taming enterprise paperwork. Is this the future?

As tms partners with FourKites, the era of AI-driven digital twins is reshaping supply chains from reactive to predictive, securing a vital competitive edge.

After a clinical hold on its lead drug, Quantum BioPharma is spending heavily on marketing. Is it a bold play for survival or a sign of desperation?

On July 22, Samsung will unveil its next-gen foldables in London. It's more than a launch; it's a strategic defense of its market leadership in the AI era.

As autism diagnoses climb, the ABA therapy industry faces a critical test. Acorn Health’s new CFO hire signals a push for scale, but also a deeper challenge.

A new partnership brings Brazilian innovator Vydence Medical to the US, offering modular, high-end laser platforms at a fraction of the cost. Is this the end of the $250k device?

MEDIPOST's Phase III trial for knee osteoarthritis isn't just a medical milestone; it's a test case for a faster regulatory path using global data.

A new skincare launch reveals a strategic blueprint for the future of aesthetics: a closed-loop network of authenticated tech, treatment, and at-home care.